Investigation on the prevalence and the types of female sexual dysfunction（FSD） of 298 cases perimenopause women

doi:10.3969/j.issn.1006-7795.2014.04.003

Journal of Capital Medical University ›› 2014, Vol. 35 ›› Issue (4): 397-401.doi: 10.3969/j.issn.1006-7795.2014.04.003

Investigation on the prevalence and the types of female sexual dysfunction（FSD） of 298 cases perimenopause women

Wang Qianqian¹, Ruan Xiangyan¹, Tian Xuanxuan¹, Cui Yamei¹, Du Juan¹, Diethelm Wallwiener², Alfred O. Mueck^1,2, Dai Yinmei¹

1. Department of Gynecological Endocrinology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, China;
2. Department of Endocrinology, University Women's Hospital of Tubingen, Tuebingen D-72076, Germany

Received:2014-06-10 Online:2014-08-21 Published:2014-07-22
Supported by:
This study was supported by National Natural Science Foundation of China(30872745), the Natural Science Foundation of Beijing(3082011), Beijing Municipality Health Technology High-level Talent(2009-3-52) and Project of discipline leader, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital(2013-1).

Abstract

Abstract:

Objective To investigate the prevalence and the types of female sexual dysfunction(FSD) of perimenopause women in our clinic, and the influence of menopause, age, smoking, cohabitation time, the number of pregnancy and depression on female sexual function. Methods This was a cross-sectional study. The patients from Dept. of Gynecological Endocrinology in Beijing Obstetrics and Gynecology Hospital affiliated to Capital Medical University and menopausal women from different communities of Heilongjiang and Shandong Province were investigated with questionnaires of FSFI and self rating Depression Scale(SDS). All data were analyzed by SPSS 13.0. Results A total of 500 questionnaires were granted and 92.2% of those were recovered. 298 questionnaires were included for analysis after screening in the end. The average total score of FSFI was 23.69 and the prevalence of FSD is 58.1% in perimenopause women according to the definition of FSD, the total score of FSFI below of 26.55, in our study. According to the 6 dimensions of FSFI, the prevalence of sexual desire disorder, sexual arousal disorder, orgasm disorder, sexual satisfaction disorder, sexual pain and vaginal lubrication disorders were 50.7%, 43.3%, 35.6%, 33.6%, 29.5% and 28.5% orderly. Higher age and depression are risks for FSD(P<0.05), menopause, the number of pregnancy, cohabitation time, smoking, drinking had no significant effect on female sexual function(P>0.05). Conclusion The prevalence of FSD of perimenopause women in our clinic is 58.1%, and the prevalence of sexual desire disorder, sexual arousal disorder, orgasm disorder, sexual satisfaction disorder, sexual pain and vaginal lubrication disorders were 50.7%, 43.3%, 35.6%, 33.6%, 29.5% and 28.5% in turn.

Key words: perimenopausal, female sexual function, Female Sexual Function Index, Self Rating Depression Scale

CLC Number:

R271.11

Wang Qianqian, Ruan Xiangyan, Tian Xuanxuan, Cui Yamei, Du Juan, Diethelm Wallwiener, Alfred O. Mueck, Dai Yinmei. Investigation on the prevalence and the types of female sexual dysfunction（FSD） of 298 cases perimenopause women[J]. Journal of Capital Medical University, 2014, 35(4): 397-401.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2014.04.003

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2014/V35/I4/397

References

[1] 谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:389-390.
[2] Aslan E, Fynes M. Female suxual dysfunction[J]. Int Urogynecol J Pelvic Floor Dysfunct, 2008,19(2):293-305.
[3] Meston C M. Validation of the femal sexual function index(FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire discorder[J]. J sex Marital Ther, 2003,29(1):39-46.
[4] Basson R, Berman J, Burnell A, et al. Report of the international consensus development conference on femal sexual dysfunction:definitions and classifications[J]. J Urology, 2000,163(3):888-893.
[5] Iauman E O, Paik A, Rosen R C. Sexual dysfunction in the United States:prevalence and predictors[J]. JAMA, 1999,281(6)537-544.
[6] Barrett G, Pendry E, Peacock J, el al. Women's sexual health after childbirth[J]. BJOG, 2000,107(2):186-195.
[7] Song S H, Jeon H, Kim S W, et al. The prevalence and risk factors of female sexual dysfunction in young Korean women: an internet-based survey[J]. J Sex Med, 2008,5(7):1694-1701.
[8] Kim Y H, Kim S M, Kim J J, et al. Does metabolic syndrome impair sexual function in middle-to old-aged women?[J]. J Sex Med, 2011,8(4):1123-1130.
[9] Singh J C, Tharyan P, Kekre N S, et al. Prevalence and risk factors for female sexual dysfunction in women attending a medical clinic in south India[J]. J Postgrad Med, 2009,55(2):113-120.
[10] Pace G, Silvestri V, Gualá L, et al. Body mass index, urinary incontinence, and female sexual dysfunction: how they affect female postmenopausal health[J]. Menopause, 2009,16(6):1188-1192.
[11] Wallwiener C W, Wallwiener L M, Seeger H, et al. Prevalence of sexual dysfunction and impact of contraception in female German medical students[J]. J Sex Med, 2010,7(6):2139-2148.
[12] Wallwiener M, Wallwiener L M, Seeger H, et al. Effects of sex hormones in oral contraceptives on the female sexual function score:a study in German femal medical students[J]. Contraception, 2010,82(2):155-159.
[13] Veronelli A, Mauri C, Zecchini B, et al. Sexual dysfunction is frequent in premenopausal women with diabetes, obesity, and hypothyroidism, and correlates with markers of increased cardiovascular risk. A Preliminary Report[J]. J Sex Med, 2009,6(6):1561-1568.
[14] Nusbaum M R, Gamble G, Skinner B, et al. The high prevalence of sexual concerns among women seeking routine gynecological care[J]. J Fam Pract, 2000,49(3):229-232.

Investigation on the prevalence and the types of female sexual dysfunction（FSD） of 298 cases perimenopause women

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 4

Recommended Articles

Metrics

Comments

[1]	Ju Rui, Ruan Xiangyan, Dai Yinmei, Bai Yongtao, Yang Xingzi, Shi Yanhong, Xu Xin, Yang Yu, Cheng Jiaojiao, Sun Yanhua, Li Ruiling. Study on the situation of female sexual dysfunction in different reproductive aging stages and postmenopausal women using hormone replacement therapy [J]. Journal of Capital Medical University, 2021, 42(4): 533-539.
[2]	Du Juan, Ruan Xiangyan, Alfred O. Mueck. Effects of oral contraceptives on sexual function in PCOS patients [J]. Journal of Capital Medical University, 2018, 39(4): 499-504.
[3]	Jin Fengyu, Ruan Xiangyan, Alfred O. Mueck, Liu Yulan, Du Juan. Investigation and analysis of sexual status of perimenopausal women in Beijing and its surrounding areas [J]. Journal of Capital Medical University, 2017, 38(4): 509-514.
[4]	Lai Ailuan;Zhang Lisong;Jiang Guiying;Jin Qiaofeng;Sun Yange . The Therapeutic Effects of Progestin on Perimenopuasal Syndrome [J]. Journal of Capital Medical University, 2006, 27(6): 836-838.